ABSCI CORP (ABSI) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $7.16M; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value $1.40M; Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value (m); Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $7.16M | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $7.16M |
| Deferred revenue · latest quarter (USD) | $1.40M | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. $1.15M + $240.00K ≈ $1.40M |
| Other obligations · due within 1 year (USD) | (m) | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due after 1 year (USD) | $1.31M | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. $1.31M − $0.00 ≈ $1.31M |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 22.79M USD | Liabilities |
| Borrowing debt | (m) | |
| Amounts owed to suppliers | 7.16M USD | Accounts Payable, Current |
| Total deferred revenue | 1.40M USD | Contract with Customer, Liability · Contract with Customer, Liability, Current · Contract with Customer, Liability, Noncurrent |
| Deferred revenue due within one year | 1.15M USD | Contract with Customer, Liability, Current |
| Deferred revenue due after one year | 240.00K USD | Contract with Customer, Liability, Noncurrent · Contract with Customer, Liability · Contract with Customer, Liability, Current |
| Reported other obligations due within one year | (m) | |
| Reported other noncurrent obligations | 1.31M USD | Other Liabilities, Noncurrent |
| Deferred revenue included in other noncurrent obligations | 0.00 USD | Contract with Customer, Liability · Contract with Customer, Liability, Current |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- (m)
- Other obligations · due after 1 year (USD)
- $1.31M
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Operating lease obligations | $3.68M |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $7.16M | $1.40M | (m) | $1.31M | $22.79M | (m) | $1.15M | $240.00K | $1.31M | $0.00 |
| 2026-03-31 | (m) | $8.82M | $1.00M | (m) | $806.00K | $23.62M | (m) | $450.00K | $641.00K | $806.00K | $0.00 |
| 2025-12-31 | (m) | $2.76M | $1.20M | (m) | $1.02M | $26.85M | (m) | $739.00K | $436.00K | $1.02M | $0.00 |
| 2025-09-30 | (m) | $4.59M | $1.60M | (m) | $1.27M | $34.65M | (m) | $1.08M | $519.00K | $1.79M | $519.00K |
| 2025-06-30 | (m) | $8.21M | $1.00M | (m) | $1.44M | $36.52M | (m) | $954.00K | $46.00K | $1.48M | $46.00K |
| 2025-03-31 | (m) | $4.95M | $1.10M | (m) | $1.68M | $33.65M | (m) | $1.10M | $4.00K | $1.69M | $4.00K |
| 2024-12-31 | (m) | $3.53M | $1.10M | (m) | $133.00K | $34.48M | (m) | $1.12M | $0.00 | $133.00K | $0.00 |
| 2024-09-30 | (m) | $1.67M | $1.80M | (m) | $31.00K | $33.90M | (m) | $1.78M | $0.00 | $31.00K | $0.00 |
| 2024-06-30 | (m) | $1.69M | $2.00M | (m) | $15.00K | $34.04M | (m) | $1.97M | $0.00 | $15.00K | $0.00 |
| 2024-03-31 | (m) | $1.65M | $3.20M | (m) | $78.00K | $34.79M | (m) | $3.06M | $180.00K | $78.00K | $0.00 |
| 2023-12-31 | (m) | $1.50M | $4.10M | (m) | $33.00K | $41.12M | (m) | $3.17M | $966.00K | $33.00K | $0.00 |
| 2023-09-30 | (m) | $1.91M | $300.00K | (m) | $45.00K | $39.93M | (m) | $345.00K | $-45.00K | $0.00 | $-45.00K |
| 2023-06-30 | (m) | $1.85M | $500.00K | (m) | $0.00 | $38.75M | (m) | $500.00K | $0.00 | $0.00 | $0.00 |
| 2023-03-31 | (m) | $1.93M | $400.00K | (m) | $-41.00K | $41.84M | (m) | $359.00K | $41.00K | $0.00 | $41.00K |
| 2022-12-31 | (m) | $2.41M | $400.00K | (m) | $80.00K | $46.59M | (m) | $445.00K | $-45.00K | $35.00K | $-45.00K |
| 2022-09-30 | (m) | $1.86M | $700.00K | (m) | $12.00K | $46.45M | (m) | $679.00K | $21.00K | $33.00K | $21.00K |
| 2022-06-30 | (m) | $5.47M | $2.80M | (m) | $225.00K | $50.12M | (m) | $2.80M | $2.00K | $227.00K | $2.00K |
| 2022-03-31 | (m) | $6.74M | $2.80M | (m) | $213.00K | $54.96M | (m) | $2.79M | $9.00K | $222.00K | $9.00K |
| 2021-12-31 | (m) | $8.38M | $1.40M | (m) | $12.12M | $60.09M | (m) | $1.35M | $47.00K | $12.16M | $47.00K |
| 2021-09-30 | (m) | $6.37M | $2.10M | (m) | $12.13M | $61.11M | (m) | $1.97M | $122.00K | $12.13M | $0.00 |
| 2021-06-30 | (m) | $9.00M | $2.60M | (m) | $18.49M | $219.96M | (m) | $1.77M | $839.00K | $18.49M | $0.00 |
| 2020-12-31 | (m) | $2.12M | $2.60M | (m) | $749.00K | $21.56M | (m) | $2.63M | $0.00 | $749.00K | $0.00 |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |